Health Case Studies

AbRegen and Ferronova

AbRegen is a preclinical stage biotechnology company that specialises in the development of antibody-based
therapeutics for tissue repair applications.

Ferronova is a cancer diagnostics company, developing magnetic probe and tracer systems for improved lymph node identification.

Tech Flyers

14-3-3 Cancer Therapeutics

A novel class of 14-3-3 targeting anti-cancer drugs.

Advancing Prognostic Tests for Multiuple Myeloma

A novel biomarker based test for better prognosis of patients with multiple myeloma.

Australian Bush Bioactives

Australian Indigenous native plant bioactive extracts and compounds with potent non-steroidal anti-inflammatory activity.

Assay Ready Plates

Off the shelf solution for drug response testing.


Painless, low cost and safe bioactive delivery system.

Interleukin-3 Receptor

A monoclonal antibody targeting the Interleukin-3 receptor to treat triple negative breast cancer.

Inulin-Lipid  Hybrid (ILH) Technology

Dry powder formulation that affords high drug and lipid stability through the micro-encapsulation approach.

Liquid Crystal Nanoparticles (LCNP) Enhances Antimicrobial Efficiency

Novel formulation approach that direct antibiotics into biofilm (chronic) infections, enhancing the efficacy of cationic antimicrobials by at least 100-fold against biofilm bacterial infections.

MYB Inhibitors

In development for treatment of Acute Myeloid Leukaemia (AML) and other Cancers.

Polymer-lipid Hybrid (PLH) Microparticles

A novel hybrid drug delivery formulation that can be used in a wide range of therapeutic applications.

Ultra Low Attachment (ULA) Coatings

Adaptable surface coating to deter cells from attaching.

Variant Grid

A graphical user interface that allows non-experts to filter, search and analyse a patient’s genetic variants in a database.